Skip to main content
Retour
Watch Compare

MAINZ BIOMED N.V.

Qualité des données : 100%
QUCY
Nasdaq Manufacturing Chemicals
0,48 €
▼ 0,04 € (-7,71%)
Cap. Boursière: 6,00 M
Prix
0,48 €
Cap. Boursière
6,00 M
Fourchette du Jour
0,46 € — 0,52 €
Fourchette 52 Semaines
0,40 € — 4,43 €
Volume
545 616
Ouverture 0,50 €
Moyenne 50J / 200J
0,77 €
37,65% below
Moyenne 50J / 200J
1,29 €
62,94% below

Quick Summary

Points Clés

Negative free cash flow of -10,98 M
Capital efficient — spends only 0,23% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-2526,61%
En dessous de la moyenne du secteur (-53,41%)
ROIC-492,09%
Net Margin-3018,31%
Op. Margin-3004,97%

Sécurité

Debt / Equity
1,49
Au-dessus de la moyenne du secteur (0,31)
Current Ratio0,50
Interest Coverage-43,22

Valorisation

PE (TTM)
-0,37
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio9,35
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B 9,4 1,6
ROE % -2526,6 -53,4
Net Margin % -3018,3 -41,5
Rev Growth 5Y % — 1,8
D/E 1,5 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 537 080,0 Net Income (TTM) -16,21 M
ROE -2526,61% ROA -304,29%
Gross Margin 72,58% Operating Margin -3004,97%
Net Margin -3018,31% Free Cash Flow (TTM) -10,98 M
ROIC -492,09% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,49 Current Ratio 0,50
Interest Coverage -43,22 Asset Turnover 0,10
Working Capital -1,85 M Tangible Book Value -471 824
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,37 Forward P/E N/A
P/B Ratio 9,35 P/S Ratio 11,17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -183,06%
Market Cap 6,00 M Enterprise Value 6,96 M
Per Share
EPS (Diluted TTM) -2,70 Revenue / Share 0,04
FCF / Share -0,88 OCF / Share -0,88
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,23% FCF Conversion 67,74%
SBC-Adj. FCF -12,45 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 537 080,0
Net Income -16,21 M
EPS (Diluted) -2,70
Gross Profit 389 792,0
Operating Income -16,14 M
EBITDA —
R&D Expenses 4,91 M
SG&A Expenses —
D&A 615 720,0
Interest Expense 373 458,0
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 5,33 M
Total Liabilities 4,69 M
Shareholders' Equity 641 600,0
Total Debt 956 902,0
Cash & Equivalents —
Current Assets 1,84 M
Current Liabilities 3,69 M